Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
Contact Hyperliquid Strategies Inc
477 Madison Avenue, 22nd Floor
New York, NY 10022
investors@hypestrat.xyz
Contact Sonnet BioTherapeutics
100 Overlook Center
Princeton, NJ 08540
info@sonnetbio.com
Sonnet Biotherapeutics Investor Contact
JTC Team, LLC
Jenene Thomas
908-824-0775
SONN@jtcir.com